Ramón Mangues

18PUBLICATIONS
42CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 02, 2026
PM534, a Novel Colchicine Site Tubulin Inhibitor with Broad-Spectrum and Resistance-Overcoming Antitumor Activity.

Pablo Aviles, Marcelo Lima Ribeiro, Maria Jose Guillén

|Mar 04, 2025
A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation.

Luis Miguel Carrasco-Díaz, Alberto Gallardo, Eric Voltà-Durán

|Jun 19, 2024
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas.

Anna C Virgili, Juliana Salazar, Alberto Gallardo

|Mar 29, 2023
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo.

Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs

|Jan 08, 2023
Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models.

Esperanza Medina-Gutiérrez, Annabel García-León, Alberto Gallardo

|Jul 27, 2022
Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease.

Esperanza Medina-Gutiérrez, María Virtudes Céspedes, Alberto Gallardo

Pageof 3

Frequent Collaborators

9 joint publications

Antonio Villaverde

7 joint publications

Esther Vázquez

7 joint publications

Ugutz Unzueta

5 joint publications

Lorena Alba-Castellón